MUMBAI (TIP): Germany‘s drug regulator has banned the sale of 80 generic medicines with immediate effect on grounds of “deficiencies” in the clinical trials conducted by domestic pharma company GVK Biosciences. The ban comes after regulators in Germany, France and Belgium last week suspended marketing approval of 25 generic drugs. The list of banned drugs includes those for treating high blood pressure, depression, migraine and epilepsy, and are manufactured by Dr Reddy’s, Lupin, Micro Labs and Torrent, among others.
Be the first to comment